Association of Cigarette Type With Lung Cancer Incidence and Mortality: Secondary Analysis of the National Lung Screening Trial

Nichole T Tanner; Nina A Thomas; Ralph Ward; Alana Rojewski; Mulugeta Gebregziabher; Benjamin Toll; Gerard A Silvestri

doi:10.1001/jamainternmed.2019.3487

Association of Cigarette Type With Lung Cancer Incidence and Mortality: Secondary Analysis of the National Lung Screening Trial

JAMA Intern Med. 2019 Dec 1;179(12):1710-1712. doi: 10.1001/jamainternmed.2019.3487.

Authors

Nichole T Tanner^{1

2

3}, Nina A Thomas², Ralph Ward^{1

4}, Alana Rojewski^{3

4}, Mulugeta Gebregziabher^{1

2

4}, Benjamin Toll^{2

3

4}, Gerard A Silvestri^{2

3}

Affiliations

¹ Health Equity and Rural Outreach Innovation Center (HEROIC), Ralph H. Johnson Veterans Affairs Hospital, Charleston, South Carolina.
² Thoracic Oncology Research Group, Medical University of South Carolina, Charleston.
³ Hollings Cancer Center, Medical University of South Carolina, Charleston.
⁴ Department of Public Health Sciences, Medical University of South Carolina, Charleston.

Abstract

This study uses data from the National Lung Screening Trial to investigate the association of cigarette tar level, flavor, and filter status with lung cancer diagnosis, mortality, and all-cause mortality.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Aged
Early Detection of Cancer
Female
Humans
Incidence
Lung / diagnostic imaging*
Lung Neoplasms / diagnostic imaging
Lung Neoplasms / epidemiology*
Lung Neoplasms / mortality
Male
Mass Screening
Middle Aged
Risk Factors
Surveys and Questionnaires
Survival Rate
Tobacco Products
Tomography, X-Ray Computed

Grants and funding

K07 CA214839/CA/NCI NIH HHS/United States